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INTRODUCTION:
Premenstrual syndrome refers to distressing physical,
psychological and behavioural symptoms not caused by
organic disease, which regularly occurs during the luteal
phase of menstrual cycle and significantly regresses or
disappears during the remainder of the cycle.1,2,3,4
Premenstrual syndromes (PMS) are quite prevalent among
women of reproductive age. Even though the etiology of
PMS is still unknown, several treatment modalities have
been shown to be effective. Diagnosis ofpremenstrual
syndrome is made when the symptoms occur before the
onset of menstrual periods and subside a few days after
they start. These symptoms may be physical or
psychological, and they vary in severity from mild,
moderate to severe. Depending on the severity of the
symptoms, it could be unbearable and leads to disruption
of work and social life of women who are afflicted by
it. Despite the prevalence of the disorder, the availability
of treatment and media exposure, many lay people and
professionals are still unaware of its impact on the
individual, her family and environment5,6,7. Premenstrual
impairment may be more severe at home, influencing
marital relationships and homemaking, as compared to
social and out-of-home occupational impairment.8
A lot of premenstrual complaints have been reported in
patients with PMS. Only a handful of these symptoms
are consistently assessed and identified in studies, most
commonly irritability, tension, depression, bloating,
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mastalgia, and headache.9,10,11,12
Premenstrual syndrome is often classified under the
generic term Premenstrual Syndrome which is listed in
the International Statistical Classification of diseases and
Related Health Problems, 10th revision (ICD-10).The
DSM-IV research criteria for this disorder help to identify
and classify women who experience severe psychological
symptoms during the premenstrual phase.13,14,15 DSM-
IV defines the premenstrual syndrome (PMS) as a separate
entity: premenstrual symptoms must occur in the last
week before the start of menstrual cycle and remit within
a few days of the onset of menses; they must also be
severe enough to interfere with work, family and social
relationships; at least 4 symptoms (including at least one
of the major dysphoric symptom out of a list of 11 must
be present.
Despite its official statusrecognized globallyas a medical
disorder,16 it is rarely discussed in Pakistan and is
surrounded by stigma which leads to lot of
misconceptions.17 Our research was not confined to any
specific age group. It has been estimated from
retrospective community surveys that nearly 90% of
women have experienced at least one premenstrual
syndrome (PMS) as defined by ICD-10 criteria. It is
notable that the majority of women suffering from
premenstrual syndromePMS (55%) in this study, never
used any treatment or medication to relieve their
symptoms. This is the cultural influence that Pakistani
women accept to believe that these symptoms are part
of being a woman rather than complain about it, there
are more pains to bear as a woman. Education about
body physiology and counselling for Pakistani women,
especially the less privileged one, is recommended to
educate the people about Premenstrual syndrome, and to
reduce its incidence and improve the quality of life in
the affected.18
Research has been done on PMS in many countries but
very few studies have been reported on the experience
of Pakistani women. This study has been conducted to
find out the prevalence of premenstrual syndrome(PMS)
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The study was conducted in various cities of Pakistan
that is Islamabad, Quetta, Karachi, Multan, Hyderabad
at different hospitals, universities, colleges and shopping
malls. It took 6 months i.e. from 1st August 2010 to 31st
January 2011 to collect and analyze the data. The team
asked the participants to fill outa self administered closed
ended questionnaire designed using the validated criterion
of DSM IV. All women of reproductive age who gave
verbal consent were included in the study. Women who
were pregnant, lactating, wanted new pregnancy, taking
contraceptive pills or injections and with cycles more
than 35 days in length were excluded from the study.
Women with medical disorder such as thyroid disease,
irregular menstrual cycle and psychiatric disorders were
also excluded.Symptoms studied were physical,
psychological and behavioral. Each women enrolled in
this study was followed for two consecutive cycles. The
ratings were prospectively completed for 2 menstural
cycles. The days of the period and the days on which the
symptoms caused any dysfunction were studied
separately.Last week of the luteal phase i.e. the week
before onset of menstruation was compared with first
week of follicular phase, beginning on day 2 of the same
cycle. Numbers of the symptoms present were noted on
each day of luteal phase starting from day 14 of the same
cycle, assuming total cycle length to be 28 days. It was
also asked in the questionnaire if symptoms were relieved
with onset of menstruation.
Study Tool:
The questionnaire for study was designed on DSM IV
criteria according to which there are 11 premenstrual
syndrome symptoms based on occurrence and severity,
labeled to diagnose PMS. If 4 of them are positive, than
a female is suffering from PMS.DSM-IVcriteria was
used by the American Psychiatric Association to diagnose
premenstrual syndrome which is called premenstrual
dysphoric disorder. This is characterized by the presence
of at least five symptoms (one of which must be affective)
that occur in the late luteal phase, are not a luteal
exacerbation of an existing psychiatric condition, that
significantly interferes with social activities or
relationships with others. Symptoms are depressed mood,
anxiety and tension, fluctuating moods, anger and
irritability, decreased interest, poor concentration, lethargy
and fatigue, change in appetite, feeling overwhelmed
and out of control. Physical symptoms include breast
tenderness and weight gain.
Sample Size: The sample size was 382, calculated by
using standard statistical formula.
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RESULTS:
Out of 382 women included in the study, 143 were
married and 239 were single (Fig 1a). Women belonged
to a diverse economic strata and ethnic backgrounds.
The prevalence of premenstrual syndrome was 55%. The
commonsymptoms occurring in PMS weredepression,
tension and irritability, labile mood, bloating, swollen
breast, increased appetite, sleeping disturbances and
headache.
Prevalence of depression was 147 (fig 1b). Prevalence
of tension and irritability was 204(Fig 2a)  labile mood
was 261(fig 2b), bloating and body aches was 306 (Fig
2c). Headache was present in 277 (Fig 2d). Swollen
breast was69, sleep disturbance i.e. insomnia was 158
and increased appetite was 132 and headache was 277
((fig 3).
Fig 1b.Depression
Fig 1a.Ratio of single vs. married women
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Blue colour shows positive results
Fig 2.
Fig 3. Swollen breast, sleep disturbance (insomnia) and increased appetite
a) Tension and irritability b) Labile mood c) Body aches d) Headache
DISCUSSION:
It has been estimated that as many as 80% of women of
reproductive age may be suffering from some symptoms
of Premenstrual syndrome. Premenstrual syndrome, a
common cyclic disorder of young and middle-aged
women, is characterized by emotional and physical
symptoms that consistently occur during the luteal phase
of the menstrual cycle. Premenstrual syndrome is a
diagnosis of exclusion; therefore, alternative explanations
for symptoms must be considered before either diagnosis
is made. The disorders can manifest with a wide variety
of symptoms, including depression, mood liability,
abdominal pain, breast tenderness, headache, and fatigue.
However, mood symptoms--anxiety, irritability, and mood
liability were the most stable symptoms in this group of
women with PMS.
Although the etiology of these disorders remains uncertain,
research suggests that altered regulation of neurohormones
and neurotransmitters is involved.The three classes of
endogenous opioid peptides are endorphins, enkephalins
anddynorphins. Beta-endorphin is the major representative
of endogenous opioid peptides.Previous studies have
suggested the symptoms of Premenstrual syndrome may
be due to noradrenergic rebound following beta-endorphin
decline20,21,22,23,24. Women with PMS should be instructed
about lifestyle changes, including healthy diet, sodium
and caffeine restriction, exercise, and stress reduction.
Supportive strategies, such as use of a symptom diary,
may be helpful in diagnosing and managing the disorders.
In women with moderate symptoms, treatment includes
both medication and lifestyle modifications. Dietary
supplements, such as calcium and evening primrose oil,
may offer modest benefit. Many researchers suggest that
a variety of nutrients may have an important function in
the phase related mood and behavioural disturbances of
the premenstrual syndrome. Different studies suggest, at
least  a little of these micronutrients, mainly calcium and
vitamin D, supporting cyclic fluctuations throughout the
menstrual cycle that may  explain some features of pre-
menstrual syndrome (PMS).25
Ovarian hormones have an influence on calcium,
magnesium and vitamin D metabolism. Estrogen regulates
the calcium metabolism, intestinal calcium absorption
and parathyroid hormone secretion, causing fluctuations
during menstrual cycle. The similarity between the
findings of premenstrual syndromelike depression, anxiety
and behavioural changes. andhypocalcemia is significant.
Clinical trials suggest that blood calcium and vitamin D
levels are lesser in women with premenstrual syndrome
and that calcium supplementation has reduced the severity
of symptoms. This put forwards that PMS represents the
clinical appearance of a calcium deficiency state which
is revealed by the rise of ovarian steroid hormone
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concentrations during the menstrual cycle. So the
possibility of suffering from premenstrual syndrome is
lower in women who consume more dairy products in
daily life.
Selective serotonin reuptake inhibitors such as fluoxetine
and sertraline are the most effective pharmacologic
agents.Serotonin deficiency is proposed because patients
who are most influenced by PMS have decreased level
of serotonin. Selective serotonin reuptake inhibitors
(SSRIs),the medications that increase the level of
circulating serotonin are reported to relieve the symptoms
of premenstrual syndrome. Serotonin is predominantly
involved in the depressive symptoms, expression of
irritability, anger,specific food cravings, specifically
found in the premenstrual syndrome. Along with their
different effects, estrogens increase the density of
serotonin receptors enhancing the sensitivity to serotonin
agonists.26,27.
Prostaglandin inhibitors and diuretics may provide some
relief of symptoms.Usually the women with premenstrual
syndrome have an exaggerated response to normal
hormonal changes, Rapidly shifting levels of estrogen
and progesterone promote pronounced emotional,
behavioral and physical responses, although their
hormonal levels are similar to women without
premenstrual syndrome. Only weak evidence supports
the effectiveness of gonadotropin-releasing hormone
agonists, androgenic agents, estrogen, progesterone, or
other psycho-tropics, and side effects limit their use 28,29.
The Premenstrual syndrome was considered for a long
time resembling a somatic disease, but currently the
psychiatric symptoms severity justifies most often the
medical cares. In order to discriminate some isolated and
mild complaints, of a disabling disorder, the standardized
prospective auto-assessment is the most applicable
method.Ultimately, intermittent prescription of serotonin
re-uptake inhibitors appears to be an effective treatment
30. As not a single drug has been proven valuable in the
treatment of premenstrual syndrome, consequently, its
management includes education, reassurance and drug
therapy.  There is a need to build up methods to conduct
the trials in rural and urban areas to find out the exact
prevalence of the disease. There is a need to recognize
the syndrome and develop perception regarding its
assessment, diagnosis and treatment among the physicians.
CONCLUSION:
Premenstrual syndrome is a common cyclic disorder of
young and middle-aged women that is poorly recognized
and inadequately treated. Physical and emotional
symptoms are quite common in the luteal phase of the
Pakistani women and have a significant impact on their
daily life activities..Doctors should adopt comprehensive
measures to reduce its prevalence and improve the quality
of life in the affected population.
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